Showing results 17 to 30 of 30
< previous
| Issue Date | Title | Author(s) |
| 2017-05-16 | PD-L1 expressing circulating tumour cells in head and neck cancers | Kulasinghe, A; Perry, C; Kenny, L; Warkiani, ME; Nelson, C; Punyadeera, C |
| 2019-03-18 | Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets. | Kulasinghe, A; Kapeleris, J; Cooper, C; Warkiani, ME; O'Byrne, K; Punyadeera, C |
| 2018-08-14 | The prognostic role of circulating tumor cells (CTCs) in lung cancer | Kapeleris, J; Kulasinghe, A; Warkiani, ME; Vela, I; Kenny, L; O'Byrne, K; Punyadeera, C |
| 2016-09-13 | Short term ex-vivo expansion of circulating head and neck tumour cells. | Kulasinghe, A; Perry, C; Warkiani, ME; Blick, T; Davies, A; O'Byrne, K; Thompson, EW; Nelson, CC; Vela, I; Punyadeera, C |
| 2022-09 | Single-cell analysis of circulating tumour cells: enabling technologies and clinical applications. | Radfar, P; Aboulkheyr Es, H; Salomon, R; Kulasinghe, A; Ramalingam, N; Sarafraz-Yazdi, E; Thiery, JP; Warkiani, ME |
| 2021 | The Effects of COVID-19 on the Placenta During Pregnancy. | Rad, HS; Röhl, J; Stylianou, N; Allenby, MC; Bazaz, SR; Warkiani, ME; Guimaraes, FSF; Clifton, VL; Kulasinghe, A |
| 2020-01 | The evolving landscape of predictive biomarkers in immuno-oncology with a focus on spatial technologies. | Sadeghi Rad, H; Bazaz, SR; Monkman, J; Ebrahimi Warkiani, M; Rezaei, N; O'Byrne, K; Kulasinghe, A |
| 2021-07-19 | The Pandora’s Box of novel technologies that may revolutionize lung cancer | Rad, HS; Rad, HS; Shiravand, Y; Radfar, P; Arpon, D; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2021 | The Role of Circulating Biomarkers in Lung Cancer. | Herath, S; Sadeghi Rad, H; Radfar, P; Ladwa, R; Warkiani, M; O'Byrne, K; Kulasinghe, A |
| 2020-06-15 | The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells. | Kulasinghe, A; Lim, Y; Kapeleris, J; Warkiani, M; O'Byrne, K; Punyadeera, C |
| 2021-01-01 | Understanding the tumor microenvironment for effective immunotherapy. | Sadeghi Rad, H; Monkman, J; Warkiani, ME; Ladwa, R; O'Byrne, K; Rezaei, N; Kulasinghe, A |
| 2022 | Understanding the tumor microenvironment in head and neck squamous cell carcinoma. | Rad, HS; Shiravand, Y; Radfar, P; Ladwa, R; Perry, C; Han, X; Warkiani, ME; Adams, MN; Hughes, BG; O'Byrne, K; Kulasinghe, A |
| 2018-08-10 | The use of microfluidic technology for cancer applications and liquid biopsy | Kulasinghe, A; Wu, H; Punyadeera, C; Warkiani, ME |
| 2024 | Whole transcriptome profiling of placental pathobiology in SARS-CoV-2 pregnancies identifies placental dysfunction signatures. | Stylianou, N; Sebina, I; Matigian, N; Monkman, J; Doehler, H; Röhl, J; Allenby, M; Nam, A; Pan, L; Rockstroh, A; Sadeghirad, H; Chung, K; Sobanski, T; O'Byrne, K; Almeida, ACSF; Rebutini, PZ; Machado-Souza, C; Stonoga, ETS; Warkiani, ME; Salomon, C; Short, K; McClements, L; de Noronha, L; Huang, R; Belz, GT; Souza-Fonseca-Guimaraes, F; Clifton, V; Kulasinghe, A |
